FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer.
Saved in:
| Title: | FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer. |
|---|---|
| Authors: | Kazi A; Department of Pharmacology and Toxicology and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Vasiyani H; Department of Pharmacology and Toxicology and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Ghosh D; Department of Pharmacology and Toxicology and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia., Bandyopadhyay D; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia., Shah RD; Department of Surgery, Virginia Commonwealth University, Richmond, Virginia., Vudatha V; Department of Surgery, Virginia Commonwealth University, Richmond, Virginia., Trevino J; Department of Surgery, Virginia Commonwealth University, Richmond, Virginia., Sebti SM; Department of Pharmacology and Toxicology and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia. Electronic address: Said.Sebti@vcuhealth.org. |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Mar; Vol. 20 (3), pp. 331-344. Date of Electronic Publication: 2024 Nov 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
